SKOR1
gene geneOn this page
Also known as CORL1FUSSEL15
Summary
SKOR1 (SKI family transcriptional corepressor 1, HGNC:21326) is a protein-coding gene on chromosome 15q23, encoding SKI family transcriptional corepressor 1 (P84550). Acts as a transcriptional corepressor of LBX1.
Enables SMAD binding activity and sequence-specific double-stranded DNA binding activity. Involved in negative regulation of BMP signaling pathway. Located in dendrite and neuronal cell body.
Source: NCBI Gene 390598 — RefSeq curated summary.
At a glance
- GWAS associations: 7
- Clinical variants (ClinVar): 8 total
- MANE Select transcript:
NM_001365915
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:21326 |
| Approved symbol | SKOR1 |
| Name | SKI family transcriptional corepressor 1 |
| Location | 15q23 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | CORL1, FUSSEL15 |
| Ensembl gene | ENSG00000188779 |
| Ensembl biotype | protein_coding |
| OMIM | 611273 |
| Entrez | 390598 |
Gene structure
Transcript identifiers
Ensembl transcripts: 4 — 4 protein_coding
ENST00000341418, ENST00000380035, ENST00000554054, ENST00000554240
RefSeq mRNA: 1 — MANE Select: NM_001365915
NM_001365915
CCDS: CCDS92030
Canonical transcript exons
ENST00000380035 — 9 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001371636 | 67832607 | 67832681 |
| ENSE00001372784 | 67830191 | 67830298 |
| ENSE00001380759 | 67829179 | 67829269 |
| ENSE00001381353 | 67832274 | 67832348 |
| ENSE00001386576 | 67830818 | 67830889 |
| ENSE00001483503 | 67825509 | 67825709 |
| ENSE00003498060 | 67833192 | 67833257 |
| ENSE00003530821 | 67825936 | 67828144 |
| ENSE00003892728 | 67833742 | 67834582 |
Expression profiles
Bgee: expression breadth ubiquitous, 119 present calls, max score 76.57.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.1095 / max 42.2955, expressed in 29 samples.
FANTOM5 promoters (4 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 147364 | 0.0604 | 23 |
| 147366 | 0.0295 | 3 |
| 147367 | 0.0162 | 5 |
| 147365 | 0.0034 | 1 |
Top tissues by expression
127 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| right hemisphere of cerebellum | UBERON:0014890 | 76.57 | gold quality |
| cerebellum | UBERON:0002037 | 75.15 | gold quality |
| cerebellar cortex | UBERON:0002129 | 75.06 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 74.96 | gold quality |
| mucosa of stomach | UBERON:0001199 | 63.70 | gold quality |
| primary visual cortex | UBERON:0002436 | 62.03 | gold quality |
| ventricular zone | UBERON:0003053 | 61.77 | gold quality |
| bone marrow cell | CL:0002092 | 60.59 | gold quality |
| right frontal lobe | UBERON:0002810 | 59.36 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 58.71 | gold quality |
| cortical plate | UBERON:0005343 | 58.53 | gold quality |
| brain | UBERON:0000955 | 58.18 | gold quality |
| frontal cortex | UBERON:0001870 | 58.14 | gold quality |
| right ovary | UBERON:0002118 | 57.93 | gold quality |
| ganglionic eminence | UBERON:0004023 | 57.74 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 57.66 | gold quality |
| prefrontal cortex | UBERON:0000451 | 57.47 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 57.45 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 57.30 | gold quality |
| pituitary gland | UBERON:0000007 | 57.25 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 57.09 | gold quality |
| tibial artery | UBERON:0007610 | 56.92 | gold quality |
| popliteal artery | UBERON:0002250 | 56.89 | gold quality |
| muscle layer of sigmoid colon | UBERON:0035805 | 56.84 | gold quality |
| left ovary | UBERON:0002119 | 56.78 | gold quality |
| cerebral cortex | UBERON:0000956 | 56.54 | gold quality |
| ovary | UBERON:0000992 | 56.16 | gold quality |
| adenohypophysis | UBERON:0002196 | 56.03 | gold quality |
| skin of leg | UBERON:0001511 | 55.89 | gold quality |
| esophagogastric junction muscularis propria | UBERON:0035841 | 55.85 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 1.63 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 6)
- a novel gene, fussel-15 (functional smad suppressing element on chromosome 15) with high homology to the recently discovered Fussel-18 protein. (PMID:17292623)
- MEIS1 and LBXCOR1 are developmental factors and raise new pathophysiologic questions for RLS. (PMID:18541116)
- Permanent expression of Fussel-15 in keloid and skin sclerosis fibroblasts could be involved in the pathogenesis of these conditions. (PMID:21641385)
- MAP2K5/SKOR1 may be associated with Chinese essential tremor patients. (PMID:29798820)
- SKOR1 has a transcriptional regulatory role on genes involved in pathways related to restless legs syndrome. (PMID:32572201)
- Human alpha-synuclein overexpression upregulates SKOR1 in a rat model of simulated nigrostriatal ageing. (PMID:38529808)
Cross-species orthologs
4 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | skor1b | ENSDARG00000062448 |
| danio_rerio | skor1a | ENSDARG00000069030 |
| mus_musculus | Skor1 | ENSMUSG00000022245 |
| rattus_norvegicus | Skor1 | ENSRNOG00000013959 |
Paralogs (3): SKIL (ENSG00000136603), SKI (ENSG00000157933), SKOR2 (ENSG00000215474)
Protein
Protein identifiers
SKI family transcriptional corepressor 1 — P84550 (reviewed: P84550)
Alternative names: Functional Smad-suppressing element on chromosome 15, LBX1 corepressor 1, Ladybird homeobox corepressor 1
All UniProt accessions (3): G3V3E1, G3V5H7, P84550
UniProt curated annotations — full annotation on UniProt →
Function. Acts as a transcriptional corepressor of LBX1. Inhibits BMP signaling.
Subunit / interactions. Interacts with LBX1. Interacts with SMAD1, SMAD2 and SMAD3.
Subcellular location. Nucleus.
Tissue specificity. Present specifically in cerebellar Purkinje cells (at protein level).
Similarity. Belongs to the SKI family.
Isoforms (3)
| UniProt ID | Names | Canonical? |
|---|---|---|
| P84550-1 | 1 | yes |
| P84550-2 | 2 | |
| P84550-3 | 3 |
RefSeq proteins (1): NP_001352844* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR003380 | SKI/SNO/DAC | Domain |
| IPR009061 | DNA-bd_dom_put_sf | Homologous_superfamily |
| IPR010919 | SAND-like_dom_sf | Homologous_superfamily |
| IPR014890 | c-SKI_SMAD4-bd_dom | Domain |
| IPR023216 | Tscrpt_reg_SKI_SnoN | Family |
| IPR037000 | Ski_DNA-bd_sf | Homologous_superfamily |
Pfam: PF02437, PF08782
UniProt features (26 total): compositionally biased region 10, region of interest 6, splice variant 6, sequence variant 2, chain 1, coiled-coil region 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-P84550-F1 | 55.96 | 0.21 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 55 (showing top):
GOBP_REGULATION_OF_CELLULAR_RESPONSE_TO_GROWTH_FACTOR_STIMULUS, MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_DN, GOBP_NEGATIVE_REGULATION_OF_CELLULAR_RESPONSE_TO_GROWTH_FACTOR_STIMULUS, GOBP_REGULATION_OF_TRANSMEMBRANE_RECEPTOR_PROTEIN_SERINE_THREONINE_KINASE_SIGNALING_PATHWAY, GOBP_NEGATIVE_REGULATION_OF_BMP_SIGNALING_PATHWAY, GOBP_RESPONSE_TO_BMP, TANAKA_METHYLATED_IN_ESOPHAGEAL_CARCINOMA, GOBP_RESPONSE_TO_GROWTH_FACTOR, GOBP_REGULATION_OF_BMP_SIGNALING_PATHWAY, GOCC_NEURON_PROJECTION, chr15q23, GOMF_SMAD_BINDING, GOBP_NEGATIVE_REGULATION_OF_TRANSMEMBRANE_RECEPTOR_PROTEIN_SERINE_THREONINE_KINASE_SIGNALING_PATHWAY, LEE_TARGETS_OF_PTCH1_AND_SUFU_DN, GOCC_TRANSCRIPTION_REGULATOR_COMPLEX
GO Biological Process (5): negative regulation of transcription by RNA polymerase II (GO:0000122), regulation of DNA-templated transcription (GO:0006355), negative regulation of BMP signaling pathway (GO:0030514), negative regulation of DNA-templated transcription (GO:0045892), negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101)
GO Molecular Function (4): RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978), DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), SMAD binding (GO:0046332), sequence-specific double-stranded DNA binding (GO:1990837)
GO Cellular Component (5): nucleus (GO:0005634), transcription regulator complex (GO:0005667), cytoplasm (GO:0005737), dendrite (GO:0030425), neuronal cell body (GO:0043025)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| regulation of transcription by RNA polymerase II | 2 |
| DNA-templated transcription | 2 |
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 2 |
| transcription by RNA polymerase II | 1 |
| negative regulation of DNA-templated transcription | 1 |
| regulation of gene expression | 1 |
| regulation of RNA biosynthetic process | 1 |
| BMP signaling pathway | 1 |
| regulation of BMP signaling pathway | 1 |
| negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 1 |
| negative regulation of cellular response to growth factor stimulus | 1 |
| regulation of DNA-templated transcription | 1 |
| negative regulation of RNA biosynthetic process | 1 |
| cell surface receptor protein serine/threonine kinase signaling pathway | 1 |
| negative regulation of signal transduction | 1 |
| regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 1 |
| cis-regulatory region sequence-specific DNA binding | 1 |
| chromatin | 1 |
| DNA-binding transcription factor activity | 1 |
| protein binding | 1 |
| double-stranded DNA binding | 1 |
| sequence-specific DNA binding | 1 |
| intracellular membrane-bounded organelle | 1 |
| protein-containing complex | 1 |
| intracellular anatomical structure | 1 |
| cellular anatomical structure | 1 |
| neuron projection | 1 |
| dendritic tree | 1 |
| somatodendritic compartment | 1 |
| cell body | 1 |
Protein interactions and networks
STRING
0 interactions, top by confidence (×1000):
IntAct
3 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| SKOR1 | TRIM27 | psi-mi:“MI:0914”(association) | 0.350 |
| CD247 | RSL1D1 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (5): HDAC6 (Affinity Capture-MS), DYRK1B (Affinity Capture-MS), TRIM27 (Affinity Capture-MS), PRKAA1 (Affinity Capture-MS), SKOR1 (Proximity Label-MS)
ESM2 similar proteins: A1L020, A1L3F4, A7X8B3, A7X8B5, A7X8B7, A7X8B9, A7X8C2, A7X8C4, A7X8C7, A7X8C9, A7X8D2, A7X8D4, A7XW25, O97775, O97776, O97952, O97960, P06401, P10275, P84550, P84551, P89463, Q01JD1, Q05A36, Q0VDT2, Q3UE17, Q5PQQ7, Q5U5Q3, Q69Z36, Q6QT55, Q6ZK57, Q6ZN04, Q71FD5, Q7RTV3, Q7TSJ6, Q7XQN1, Q7XT42, Q84SL2, Q86XN8, Q8BQ89
Diamond homologs: A7M7C7, P12755, P12757, P17863, P49140, P84550, P84551, Q02225, Q1LXZ9, Q2VWA4, Q5R431, Q60665, Q60698, Q8BX46, Q9TUG2, Q925Q8, Q96NX9, H2KY91, Q9QYB2, Q9UI36
SIGNOR signaling
1 interactions.
| A | Effect | B | Mechanism |
|---|---|---|---|
| SKOR1 | “down-regulates activity” | LBX1 | binding |
Disease & clinical
Clinical variants and AI predictions
ClinVar
8 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 0 |
| Likely benign | 2 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1781 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 15:67830169:AATTC:A | acceptor_gain | 1.0000 |
| 15:67830173:C:CA | acceptor_gain | 1.0000 |
| 15:67830189:A:G | acceptor_gain | 1.0000 |
| 15:67832270:ACAG:A | acceptor_loss | 1.0000 |
| 15:67832271:C:G | acceptor_gain | 1.0000 |
| 15:67832271:CAGA:C | acceptor_loss | 1.0000 |
| 15:67832272:A:AG | acceptor_gain | 1.0000 |
| 15:67832272:AGAG:A | acceptor_gain | 1.0000 |
| 15:67832272:AGAGG:A | acceptor_loss | 1.0000 |
| 15:67832273:G:GA | acceptor_gain | 1.0000 |
| 15:67832273:GA:G | acceptor_gain | 1.0000 |
| 15:67832273:GAGG:G | acceptor_gain | 1.0000 |
| 15:67832273:GAGGA:G | acceptor_gain | 1.0000 |
| 15:67832344:CAAAG:C | donor_loss | 1.0000 |
| 15:67832345:AAAG:A | donor_loss | 1.0000 |
| 15:67832346:AAGGT:A | donor_loss | 1.0000 |
| 15:67832348:GGT:G | donor_loss | 1.0000 |
| 15:67832350:T:A | donor_loss | 1.0000 |
| 15:67832604:C:G | acceptor_gain | 1.0000 |
| 15:67832606:GA:G | acceptor_gain | 1.0000 |
| 15:67832606:GAT:G | acceptor_gain | 1.0000 |
| 15:67832606:GATA:G | acceptor_gain | 1.0000 |
| 15:67832606:GATAA:G | acceptor_gain | 1.0000 |
| 15:67833182:T:TA | acceptor_gain | 1.0000 |
| 15:67833188:CCAG:C | acceptor_loss | 1.0000 |
| 15:67833189:CAGAT:C | acceptor_loss | 1.0000 |
| 15:67833190:A:AG | acceptor_gain | 1.0000 |
| 15:67833191:G:GA | acceptor_gain | 1.0000 |
| 15:67833191:GA:G | acceptor_gain | 1.0000 |
| 15:67833191:GAT:G | acceptor_gain | 1.0000 |
AlphaMissense
6222 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 15:67826073:T:C | L82P | 1.000 |
| 15:67826078:G:T | G84W | 1.000 |
| 15:67826088:T:A | I87N | 1.000 |
| 15:67826088:T:G | I87S | 1.000 |
| 15:67826097:T:C | L90P | 1.000 |
| 15:67826117:C:A | R97S | 1.000 |
| 15:67826118:G:C | R97P | 1.000 |
| 15:67826121:T:A | L98Q | 1.000 |
| 15:67826121:T:C | L98P | 1.000 |
| 15:67826123:T:C | C99R | 1.000 |
| 15:67826124:G:A | C99Y | 1.000 |
| 15:67826125:C:G | C99W | 1.000 |
| 15:67826127:T:A | L100Q | 1.000 |
| 15:67826127:T:C | L100P | 1.000 |
| 15:67826136:T:A | I103N | 1.000 |
| 15:67826136:T:C | I103T | 1.000 |
| 15:67826136:T:G | I103S | 1.000 |
| 15:67826138:T:C | S104P | 1.000 |
| 15:67826139:C:A | S104Y | 1.000 |
| 15:67826139:C:T | S104F | 1.000 |
| 15:67826143:C:A | N105K | 1.000 |
| 15:67826143:C:G | N105K | 1.000 |
| 15:67826148:T:A | L107H | 1.000 |
| 15:67826148:T:C | L107P | 1.000 |
| 15:67826151:T:A | L108H | 1.000 |
| 15:67826151:T:C | L108P | 1.000 |
| 15:67826162:A:C | S112R | 1.000 |
| 15:67826164:C:A | S112R | 1.000 |
| 15:67826164:C:G | S112R | 1.000 |
| 15:67826165:T:C | Y113H | 1.000 |
dbSNP variants (sampled 300 via entrez): RS1000520570 (15:67824103 TCGAGAAAC>T), RS1000585256 (15:67825355 C>G,T), RS1001078886 (15:67831095 A>G), RS1001079378 (15:67829979 G>A), RS1001079651 (15:67825237 G>A), RS1001424872 (15:67827044 T>A,C,G), RS1001560064 (15:67827433 C>G), RS1002939418 (15:67833920 C>A,T), RS1003075130 (15:67834138 G>C), RS1003096782 (15:67828317 G>A,T), RS1003129090 (15:67828085 G>A), RS1003407783 (15:67833564 C>T), RS1003438833 (15:67826042 C>G), RS1003669418 (15:67831686 G>A), RS1003870479 (15:67829299 T>C)
Disease associations
OMIM: gene MIM:611273 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
7 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST000056_3 | Restless legs syndrome | 1.000000e-15 |
| GCST000830_6 | Body mass index | 1.000000e-18 |
| GCST001159_4 | Restless legs syndrome | 1.000000e-22 |
| GCST002701_14 | Verbal declarative memory | 1.000000e-06 |
| GCST005042_16 | Restless legs syndrome | 5.000000e-69 |
| GCST007280_1 | Number of twin births | 3.000000e-08 |
| GCST010917_12 | Proportion of activated microglia (midfrontal cortex) | 2.000000e-07 |
EFO canonical traits (4, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004340 | body mass index |
| EFO:0004874 | memory performance |
| EFO:0006805 | word list delayed recall measurement |
| EFO:0009439 | multiple births measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
15 total (human), top 15 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| propionaldehyde | decreases expression | 1 |
| bisphenol A | affects cotreatment, decreases methylation | 1 |
| arsenite | increases methylation | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| 2-palmitoylglycerol | increases expression | 1 |
| Fulvestrant | affects cotreatment, decreases methylation | 1 |
| Cadmium | decreases expression, increases abundance | 1 |
| Smoke | increases expression | 1 |
| Triclosan | increases expression | 1 |
| Valproic Acid | increases methylation | 1 |
| Vanadium | increases abundance, increases methylation | 1 |
| Fluorescein-5-isothiocyanate | affects binding | 1 |
| Metals, Heavy | increases abundance, increases methylation | 1 |
| Cadmium Chloride | increases abundance, decreases expression | 1 |
| S-Nitrosoglutathione | increases expression | 1 |
Cellosaurus cell lines
3 cell lines: 3 cancer cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_TL38 | HAP1 SKOR1 (-) 1 | Cancer cell line | Male |
| CVCL_XS82 | HAP1 SKOR1 (-) 2 | Cancer cell line | Male |
| CVCL_XS83 | HAP1 SKOR1 (-) 3 | Cancer cell line | Male |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): restless legs syndrome